• Reported GAAP EPS of -$1.32 down -38.95% YoY • Reported revenue of $55.93M down -5.51% YoY • Definitive Healthcare expects Q2 2026 revenue between $55M and $56M, with Adjusted EBITDA projected to be $13.5M to $14.5M, representing a 24% to 26% margin.
Bullish
Definitive Healthcare achieved increased Adjusted Net Income of $8.5M and expanded Adjusted EBITDA to $15.3M, while securing new multi-year customer deals and expanding existing client investments.
Bearish
Definitive Healthcare's Q1 2026 revenue decreased 6% to $55.9M, and Net Loss significantly increased to -$192.4M, driven by substantial goodwill impairment charges due to market capitalization decline.